Pre-eclampsia (Q59546003)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26342729%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

title

Pre-eclampsia (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26342729%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26342729%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

4

Laura A Magee

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26342729%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

1

Ben W J Mol

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26342729%20AND%20SRC:MED&resulttype=core&format=json

Christianne J.M. de Groot

23 February 2020

series ordinal

5

object named as

Christianne J M de Groot

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26342729%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Shakila Thangaratinam

series ordinal

3

object named as

Shakila Thangaratinam

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26342729%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

author name string

G Justus Hofmeyr

series ordinal

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26342729%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

language of work or name

English

0 references

publication date

2 September 2015

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26342729%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26342729%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

volume

387

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26342729%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

issue

10022

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26342729%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

page(s)

999-1011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26342729%20AND%20SRC:MED&resulttype=core&format=json

Pre-eclampsia rates in the United States, 1980-2010: age-period-cohort analysis

23 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900070-7

7 January 2021

A prospective study of maternal, fetal and neonatal deaths in low- and middle-income countries

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900070-7

7 January 2021

Moving beyond essential interventions for reduction of maternal mortality (the WHO Multicountry Survey on Maternal and Newborn Health): a cross-sectional study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900070-7

7 January 2021

Maternal preeclampsia predicts the development of bronchopulmonary dysplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900070-7

7 January 2021

Mediators of the association between pre-eclampsia and cerebral palsy: population based cohort study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900070-7

7 January 2021

Determinants of health-related quality of life in the postpartum period after obstetric complications

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900070-7

7 January 2021

Perinatal complications increase the risk of postpartum depression. The Generation R Study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900070-7

7 January 2021

The genetics of pre-eclampsia and other hypertensive disorders of pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900070-7

7 January 2021

Angiogenic factors in diagnosis, management, and research in preeclampsia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900070-7

7 January 2021

Molecular genetics of preeclampsia and HELLP syndrome - a review

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900070-7

7 January 2021

Genetic variants in pre-eclampsia: a meta-analysis.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900070-7

7 January 2021

Genetic association studies in pre-eclampsia: systematic meta-analyses and field synopsis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900070-7

7 January 2021

Maternal genotype and severe preeclampsia: a HuGE review.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900070-7

7 January 2021

Combinations of maternal KIR and fetal HLA-C genes influence the risk of preeclampsia and reproductive success

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900070-7

7 January 2021

A KIR B centromeric region present in Africans but not Europeans protects pregnant women from pre-eclampsia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900070-7

7 January 2021

Association of maternal KIR and fetal HLA-C genes with the risk of preeclampsia in the Chinese Han population

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900070-7

7 January 2021

Soluble endoglin contributes to the pathogenesis of preeclampsia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900070-7

7 January 2021

The classification, diagnosis and management of the hypertensive disorders of pregnancy: A revised statement from the ISSHP

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900070-7

7 January 2021

Diagnosis, Evaluation, and Management of the Hypertensive Disorders of Pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900070-7

7 January 2021

Hypertension in pregnancy. Report of the American College of Obstetricians and Gynecologists’ Task Force on Hypertension in Pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900070-7

7 January 2021

Can We Use the Omron T9P Automated Blood Pressure Monitor in Pregnancy?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900070-7

7 January 2021

Validation of the Omron M7 and Microlife 3BTO-A blood pressure measuring devices in preeclampsia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900070-7

7 January 2021

When are randomised trials unnecessary? Picking signal from noise

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900070-7

7 January 2021

Redefining preeclampsia using placenta-derived biomarkers.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900070-7

7 January 2021

Chronic hypertension and pregnancy outcomes: systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900070-7

7 January 2021

Risk of adverse pregnancy outcomes in women with polycystic ovary syndrome: population based cohort study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900070-7

7 January 2021

Gestational hypertension and preeclampsia in living kidney donors

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900070-7

7 January 2021

Early prediction and prevention of pre-eclampsia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900070-7

7 January 2021

Clinical risk prediction for pre-eclampsia in nulliparous women: development of model in international prospective cohort

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900070-7

7 January 2021

Circulating angiogenic factors and the risk of preeclampsia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900070-7

7 January 2021

The promise of angiogenic markers for the early diagnosis and prediction of preeclampsia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900070-7

7 January 2021

Diagnostic accuracy of placental growth factor in women with suspected preeclampsia: a prospective multicenter study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900070-7

7 January 2021

Abnormal blood biomarkers in early pregnancy are associated with preeclampsia: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900070-7

7 January 2021

First-trimester prediction of hypertensive disorders in pregnancy.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900070-7

7 January 2021

First-trimester uterine artery Doppler and adverse pregnancy outcome: a meta-analysis involving 55,974 women.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900070-7

7 January 2021

Accuracy of circulating placental growth factor, vascular endothelial growth factor, soluble fms-like tyrosine kinase 1 and soluble endoglin in the prediction of pre-eclampsia: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900070-7

7 January 2021

Can changes in angiogenic biomarkers between the first and second trimesters of pregnancy predict development of pre-eclampsia in a low-risk nulliparous patient population?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900070-7

7 January 2021

Early pregnancy prediction of preeclampsia in nulliparous women, combining clinical risk and biomarkers: the Screening for Pregnancy Endpoints (SCOPE) international cohort study.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900070-7

7 January 2021

Robust early pregnancy prediction of later preeclampsia using metabolomic biomarkers

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900070-7

7 January 2021

Antiplatelet agents for prevention of pre-eclampsia: a meta-analysis of individual patient data

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900070-7

7 January 2021

Antithrombotic therapy for improving maternal or infant health outcomes in women considered at risk of placental dysfunction

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900070-7

7 January 2021

Calcium supplementation during pregnancy for preventing hypertensive disorders and related problems

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900070-7

7 January 2021

Supplementation with vitamins C and E during pregnancy for the prevention of preeclampsia and other adverse maternal and perinatal outcomes: a systematic review and metaanalysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900070-7

7 January 2021

Magnesium supplementation in pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900070-7

7 January 2021

The role of L-arginine in the prevention and treatment of pre-eclampsia: a systematic review of randomised trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900070-7

7 January 2021

Vitamin D supplementation for women during pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900070-7

7 January 2021

Effects of interventions in pregnancy on maternal weight and obstetric outcomes: meta-analysis of randomised evidence

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900070-7

7 January 2021

Antenatal lifestyle advice for women who are overweight or obese: LIMIT randomised trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900070-7

7 January 2021

A dietary pattern characterized by high intake of vegetables, fruits, and vegetable oils is associated with reduced risk of preeclampsia in nulliparous pregnant Norwegian women

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900070-7

7 January 2021

Antepartum dalteparin versus no antepartum dalteparin for the prevention of pregnancy complications in pregnant women with thrombophilia (TIPPS): a multinational open-label randomised trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900070-7

7 January 2021

Low-molecular-weight heparin added to aspirin in the prevention of recurrent early-onset pre-eclampsia in women with inheritable thrombophilia: the FRUIT-RCT.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900070-7

7 January 2021

Serum calcium and magnesium levels in women presenting with pre-eclampsia and pregnancy-induced hypertension: a case-control study in the Cape Coast metropolis, Ghana

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900070-7

7 January 2021

Dietary calcium supplementation for prevention of pre-eclampsia and related problems: a systematic review and commentary

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900070-7

7 January 2021

Calcium supplementation during pregnancy for preventing hypertensive disorders and related problems

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900070-7

7 January 2021

Marine oil, and other prostaglandin precursor, supplementation for pregnancy uncomplicated by pre-eclampsia or intrauterine growth restriction

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900070-7

7 January 2021

Association between maternal serum 25-hydroxyvitamin D level and pregnancy and neonatal outcomes: systematic review and meta-analysis of observational studies

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900070-7

7 January 2021

Effect of supplementation during pregnancy with L-arginine and antioxidant vitamins in medical food on pre-eclampsia in high risk population: randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900070-7

7 January 2021

Nitric oxide for preventing pre-eclampsia and its complications

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900070-7

7 January 2021

Effect of diet- and lifestyle-based metabolic risk-modifying interventions on preeclampsia: a meta-analysis.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900070-7

7 January 2021

Prediction of adverse maternal outcomes in pre-eclampsia: development and validation of the fullPIERS model

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900070-7

7 January 2021

Long-term maternal and subsequent pregnancy outcomes 5 years after hemolysis, elevated liver enzymes, and low platelets (HELLP) syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900070-7

7 January 2021

How accurate are maternal symptoms in predicting impending complications in women with preeclampsia? A systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900070-7

7 January 2021

Clinical, psychosocial, and economic effects of antenatal day care for three medical complications of pregnancy: a randomised controlled trial of 395 women

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900070-7

7 January 2021

Estimation of proteinuria as a predictor of complications of pre-eclampsia: a systematic review

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900070-7

7 January 2021

Accuracy of liver function tests for predicting adverse maternal and fetal outcomes in women with preeclampsia: a systematic review

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900070-7

7 January 2021

Accuracy of serum uric acid in predicting complications of pre-eclampsia: a systematic review.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900070-7

7 January 2021

A risk prediction model for the assessment and triage of women with hypertensive disorders of pregnancy in low-resourced settings: the miniPIERS (Pre-eclampsia Integrated Estimate of RiSk) multi-country prospective cohort study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900070-7

7 January 2021

Diagnostic accuracy of spot urinary protein and albumin to creatinine ratios for detection of significant proteinuria or adverse pregnancy outcome in patients with suspected pre-eclampsia: systematic review and meta-analysis.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900070-7

7 January 2021

Risk Indicators for Eclampsia in Gestational Hypertension or Mild Preeclampsia at Term

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900070-7

7 January 2021

The role of platelet counts in the assessment of inpatient women with preeclampsia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900070-7

7 January 2021

Diagnosis, evaluation, and management of the hypertensive disorders of pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900070-7

7 January 2021

Drugs for treatment of very high blood pressure during pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900070-7

7 January 2021

Oral nifedipine versus intravenous labetalol in hypertensive urgencies and emergencies of pregnancy: a randomized clinical trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900070-7

7 January 2021

OS014. Which first-line drug to control severe hypertension in pregnancy? A pilot study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900070-7

7 January 2021

A randomized, double-blind trial of oral nifedipine and intravenous labetalol in hypertensive emergencies of pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900070-7

7 January 2021

Oral antihypertensive therapy for severe hypertension in pregnancy and postpartum: a systematic review

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900070-7

7 January 2021

Antihypertensive drug therapy for mild to moderate hypertension during pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900070-7

7 January 2021

Pharmacotherapy for preeclampsia in low and middle income countries: an analysis of essential medicines lists

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900070-7

7 January 2021

Hypertension and antihypertensive drugs in pregnancy and perinatal outcomes.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900070-7

7 January 2021

Hypertensive disorders of pregnancy: a systematic review of international clinical practice guidelines

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900070-7

7 January 2021

Do women with pre-eclampsia, and their babies, benefit from magnesium sulphate? The Magpie Trial: a randomised placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900070-7

7 January 2021

Corticosteroids for HELLP (hemolysis, elevated liver enzymes, low platelets) syndrome in pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900070-7

7 January 2021

Drug development in preeclampsia: a 'no go' area?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900070-7

7 January 2021

What is new in bed rest in pregnancy?: best articles from the past year

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900070-7

7 January 2021

Therapy with both magnesium sulfate and nifedipine does not increase the risk of serious magnesium-related maternal side effects in women with preeclampsia.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900070-7

7 January 2021

Less-tight versus tight control of hypertension in pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900070-7

7 January 2021

Selective magnesium sulfate prophylaxis for the prevention of eclampsia in women with gestational hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900070-7

7 January 2021

Maternal adverse effects of different antenatal magnesium sulphate regimens for improving maternal and infant outcomes: a systematic review

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900070-7

7 January 2021

An integrative review of the side effects related to the use of magnesium sulfate for pre-eclampsia and eclampsia management

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900070-7

7 January 2021

COHELLP: collaborative randomized controlled trial on corticosteroids in HELLP syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900070-7

7 January 2021

Committee Opinion No. 623: Emergent therapy for acute-onset, severe hypertension during pregnancy and the postpartum period

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900070-7

7 January 2021

Induction of labour versus expectant monitoring for gestational hypertension or mild pre-eclampsia after 36 weeks' gestation (HYPITAT): a multicentre, open-label randomised controlled trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900070-7

7 January 2021

Should cervical favourability play a role in the decision for labour induction in gestational hypertension or mild pre-eclampsia at term? An exploratory analysis of the HYPITAT trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900070-7

7 January 2021

Foley catheter versus vaginal prostaglandin E2 gel for induction of labour at term (PROBAAT trial): an open-label, randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900070-7

7 January 2021

Labour induction with prostaglandins: a systematic review and network meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900070-7

7 January 2021

Immediate delivery versus expectant monitoring for hypertensive disorders of pregnancy between 34 and 37 weeks of gestation (HYPITAT-II): an open-label, randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900070-7

7 January 2021

Expectant management of severe preeclampsia remote from term: the MEXPRE Latin Study, a randomized, multicenter clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900070-7

7 January 2021

Angiogenic factors and the risk of adverse outcomes in women with suspected preeclampsia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900070-7

7 January 2021

Different corticosteroids and regimens for accelerating fetal lung maturation for women at risk of preterm birth

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900070-7

7 January 2021

Effect of antenatal corticosteroids on respiratory morbidity in singletons after late-preterm birth

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900070-7

7 January 2021

Magnesium sulphate for women at risk of preterm birth for neuroprotection of the fetus

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900070-7

7 January 2021

LATE VASCULAR EFFECTS OF TOXEMIA OF PREGNANCY

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900070-7

7 January 2021

The maternal health clinic: an initiative for cardiovascular risk identification in women with pregnancy-related complications

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900070-7

7 January 2021

Lipoprotein subfraction concentrations in preeclampsia: pathogenic parallels to atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900070-7

7 January 2021

Endothelial function and circulating biomarkers are disturbed in women and children after preeclampsia.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900070-7

7 January 2021

Cardiovascular sequelae of preeclampsia/eclampsia: a systematic review and meta-analyses

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900070-7

7 January 2021

Cardiovascular risk factors in women who had hypertensive disorders late in pregnancy: a cohort study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900070-7

7 January 2021

Cardiovascular disease risk factors after early-onset preeclampsia, late-onset preeclampsia, and pregnancy-induced hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900070-7

7 January 2021

Pregnancy: a stress test for life

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900070-7

7 January 2021

Evaluating and Managing Cardiovascular Disease in Women

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900070-7

7 January 2021

Kidney disease after preeclampsia: a systematic review and meta-analysis.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900070-7

7 January 2021

Effect of postpartum lifestyle interventions on weight loss, smoking cessation, and prevention of smoking relapse: a systematic review

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900070-7

7 January 2021

Preeclampsia and long-term risk of cardiovascular disease: what do obstetrician-gynecologists know?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900070-7

7 January 2021

Hypertensive disorders of pregnancy and long-term risk of hypertension: what do Ontario prenatal care providers know, and what do they communicate?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900070-7

7 January 2021

Physicians' knowledge of future vascular disease in women with preeclampsia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900070-7

7 January 2021

Effect of an educational intervention on cardiovascular disease risk perception among women with preeclampsia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900070-7

7 January 2021

Risk of cardiovascular disease after pre-eclampsia and the effect of lifestyle interventions: a literature-based study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900070-7

7 January 2021

Lifestyle intervention in prevention of type 2 diabetes in women with a history of gestational diabetes mellitus: one-year results of the FIN-D2D project

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900070-7

7 January 2021

Pre-eclampsia and future cardiovascular risk among women: a review

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900070-7

7 January 2021

Pre-eclampsia in low and middle income countries

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900070-7

7 January 2021

Development of mHealth applications for pre-eclampsia triage

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900070-7

7 January 2021

WHO antenatal care randomised trial for the evaluation of a new model of routine antenatal care

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900070-7

7 January 2021

Antenatal care packages with reduced visits and perinatal mortality: a secondary analysis of the WHO Antenatal Care Trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900070-7

7 January 2021

Antenatal care packages with reduced visits and perinatal mortality: a secondary analysis of the WHO antenatal care trial - Comentary: routine antenatal visits for healthy pregnant women do make a difference

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900070-7

7 January 2021

Gaps between calcium recommendations to prevent pre-eclampsia and current intakes in one hospital in Argentina

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900070-7

7 January 2021

The relationship between calcium intake and edema-, proteinuria-, and hypertension-getosis: an hypothesis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900070-7

7 January 2021

Low-dose calcium supplementation for preventing pre-eclampsia: a systematic review and commentary

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900070-7

7 January 2021

Lessons for low-income regions following the reduction in hypertension-related maternal mortality in high-income countries

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900070-7

7 January 2021

A population-based, multifaceted strategy to implement antenatal corticosteroid treatment versus standard care for the reduction of neonatal mortality due to preterm birth in low-income and middle-income countries: the ACT cluster-randomised trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900070-7

7 January 2021

Reducing maternal mortality from preeclampsia and eclampsia in low-resource countries--what should work?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900070-7

7 January 2021

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900070-7

1 reference

7 January 2021

Strategy for standardization of preeclampsia research study design.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900070-7

7 January 2021

Optimising sample collection for placental research.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900070-7

7 January 2021

10.1016/S0140-6736(15)00070-7

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26342729%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

1 reference